與「Domenico Gabrielli」相符的使用者個人學術檔案

Domenico Gabrielli

Physician
在 sanita.marche.it 的電子郵件地址已通過驗證
被引用 816 次

Predicting heart failure outcome from cardiac and comorbid conditions: the 3C-HF score

…, S Nodari, M Porcu, G Cioffi, D Gabrielli… - International journal of …, 2013 - Elsevier
BACKGROUND: Prognostic stratification in heart failure (HF) is crucial to guide clinical
management and treatment decision-making. Currently available models to predict HF outcome …

Aortic dimensions in patients with bicuspid aortic valve without significant valve dysfunction

…, PL Colonna, MG Bettuzzi, S Moretti, D Gabrielli… - The American journal of …, 2005 - Elsevier
The dimensions of the entire aorta at different anatomic levels were measured by transthoracic
2-dimensional echocardiography in 162 consecutive patients with isolated bicuspid aortic …

ANMCO position paper: hospital discharge planning: recommendations and standards

…, S Egman, F Fattirolli, D Gabrielli… - European Heart …, 2017 - academic.oup.com
The hospital discharge is often poorly standardized and affected by discontinuity and
fragmentation of care, putting patients at high risk of both post-discharge adverse events and early …

Coronary plaque features on CTA can identify patients at increased risk of cardiovascular events

…, S Berti, M Canestrari, G Casolo, D Gabrielli… - JACC: Cardiovascular …, 2020 - jacc.org
Objectives : This study sought to assess whether coronary atherosclerosis analysis by coronary
computed tomography angiography (CTA) may improve prognostic stratification among …

Lifestyles and cardiovascular prevention in childhood and adolescence

…, M Benvenuto, CM Rao, SA Di Fusco, D Gabrielli… - Pediatric …, 2019 - Springer
Pathology studies demonstrated that coronary fatty streaks develop early in life and that even
more advanced fibrous plaques are present in a proportion of adolescents. The presence …

Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian …

MG Abrignani, L Gatta, D Gabrielli, G Milazzo… - European Journal of …, 2021 - Elsevier
Aspirin and P2Y 12 receptor antagonists are widely used across the spectrum of cardiovascular
and cerebrovascular diseases. Gastrointestinal complications, including ulcer and …

Lipoprotein (a): a risk factor for atherosclerosis and an emerging therapeutic target

…, A Alonzo, F Perone, MM Gulizia, D Gabrielli… - Heart, 2023 - heart.bmj.com
Lipoprotein(a) (Lp(a)) is a complex circulating lipoprotein, and increasing evidence has
demonstrated its role as a risk factor for atherosclerotic cardiovascular disease (ASCVD) and as …

Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers

…, L Sciacovelli, F Colivicchi, D Gabrielli… - Clinical Chemistry and …, 2021 - degruyter.com
In recent years, the formulation of some immunoassays with high-sensitivity analytical
performance allowed the accurate measurement of cardiac troponin I (cTnI) and T (cTnT) levels in …

[HTML][HTML] Inclisiran in lipid management: a literature overview and future perspectives

…, M De Palo, P Caldarola, F Massari, D Gabrielli… - Biomedicine & …, 2021 - Elsevier
Primary and secondary prevention protocols aim at reducing the plasma levels of lipids - with
particular reference to low-density lipoprotein cholesterol (LDL-C) plasma concentrations – …

COVID-19, vaccines, and thrombotic events: a narrative review

…, C Riccio, F Oliva, MM Gulizia, D Gabrielli… - Journal of clinical …, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19), a deadly pandemic that has affected millions of
people worldwide, is associated with cardiovascular complications, including venous and …